Latest News and Press Releases
Want to stay updated on the latest news?
-
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development...
-
WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based...
-
Financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences, Longitude Capital, and other new and existing investors Proceeds to...
-
วอลแทม รัฐแมสซาชูเซตส์ วันที่, March 07, 2024 (GLOBE NEWSWIRE) -- ในวันนี้ Zenas...
-
WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, sebuah syarikat biofarmaseutikal global yang komited untuk menjadi peneraju dalam pembangunan dan pengkomersilan terapi terarah...
-
월섬, 매사추세츠, March 07, 2024 (GLOBE NEWSWIRE) -- 염증 및 면역체계(I&I)에 기반한 치료법 개발과 상용화에 주력하는 글로벌 바이오 제약기업 제나스 바이오파마(Zenas BioPharma)가 Patricia Allen을 자사 이사회 임원으로 임명한다고 오늘 발표했다. Allen은 감사위원회 위원장도 겸직하게 된다....
-
マサチューセッツ州ウォルサム発, March 07, 2024 (GLOBE NEWSWIRE) --...
-
וולטהאם, מסצ'וסטס, March 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, חברת ביו-פארמה גלובלית המחויבת להפוך למובילה בפיתוח ומסחור של טיפולים מכווני דלקות ואימונולוגיה, הודיעה על מינויה של...
-
WALTHAM, Massachusetts, March 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, ein weltweit tätiges Biopharmazieunternehmen, dessen Ziel eine führende Rolle in der Entwicklung und Kommerzialisierung...
-
沃尔瑟姆，马萨诸塞州, March 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma 是一家全球生物制药公司，致力于成为炎症与免疫定向疗法开发和商业化的领导者，今日宣布任命 Patricia Allen 为董事会成员，同时她还将担任审计委员会主席。加入 Zenas 董事会时，Allen...